Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Repeat Dosing of Psilocybin in Headache Disorders

NCT04218539 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT04218539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04218539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Repeat Dosing of Psilocybin in Headache Disorders
Lead sponsor
Yale University
Phase
Phase 1
Overall status
Completed
Start date
August 10, 2021
Completion date
November 5, 2023
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine headache